Literature DB >> 12771442

Development of systemic lupus erythematosus in a young child affected with chronic granulomatous disease following withdrawal of treatment with interferon-gamma.

R Badolato, L D Notarangelo, A Plebani, D Roos.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12771442     DOI： 10.1093/rheumatology/keg193

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  4 in total

1.  Postmortem diagnosis of chronic granulomatous disease: how worthwhile is it?

Authors:  R Lakshman; S Bruce; D A Spencer; D Crawford; A Galloway; P N Cooper; D Barge; D Roos; T J Flood; M Abinun
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

Review 2.  Inflammatory manifestations in chronic granulomatous disease (CGD).

Authors:  S D Rosenzweig
Journal:  J Clin Immunol       Date:  2008-01-12       Impact factor: 8.317

3.  Reactive oxygen species deficiency induces autoimmunity with type 1 interferon signature.

Authors:  Tiina Kelkka; Deborah Kienhöfer; Markus Hoffmann; Marjo Linja; Kajsa Wing; Outi Sareila; Malin Hultqvist; Essi Laajala; Zhi Chen; Júlia Vasconcelos; Esmeralda Neves; Margarida Guedes; Laura Marques; Gerhard Krönke; Merja Helminen; Leena Kainulainen; Peter Olofsson; Sirpa Jalkanen; Riitta Lahesmaa; M Margarida Souto-Carneiro; Rikard Holmdahl
Journal:  Antioxid Redox Signal       Date:  2014-07-29       Impact factor: 8.401

4.  Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 Diabetes.

Authors:  Lindsey E Padgett; Brian Anderson; Chao Liu; Douglas Ganini; Ronald P Mason; Jon D Piganelli; Clayton E Mathews; Hubert M Tse
Journal:  Diabetes       Date:  2015-08-12       Impact factor: 9.461
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.